An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
We’re Not Giving Away Your Shot – Wolters Kluwer Pharmacist Explains COVID-19 Vaccine Shot vs. Booster Confusion
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
covid-19
Rhea-AI Summary
Wolters Kluwer highlights recent CDC recommendations for additional COVID-19 vaccine doses for immunocompromised individuals and the White House's suggestion for a booster shot eight months after the second dose. Kristen Nichols, a pharmacist, emphasizes the distinction between booster shots, meant to enhance waning immunity in healthy individuals, and additional doses for those who may not have responded adequately to initial vaccinations. This initiative aims to improve immune responses and provide critical protection against COVID-19.
Positive
CDC recommends additional doses for immunocompromised patients to strengthen immunity.
Potential for improved immune responses in high-risk populations may enhance public health outcomes.
Negative
Early data suggests existing vaccine regimen may be inadequate for some immunocompromised individuals.
Kristen Nichols, PharmD of Wolters Kluwer, explains that a vaccine booster is not the same as a second or third dose of the COVID-19 vaccines
WALTHAM, Mass.--(BUSINESS WIRE)--
What: The most recent recommendations from the CDC advise that immunocompromised patients receive an additional dose of the COVID-19 MRNA vaccines made by Moderna and Pfizer. The White House also announced they were recommending people start to receive a booster shot of the MRNA vaccines eight months after their second dose.
Wolters Kluwer COVID-19 Vaccine vs. Booster graphic (Graphic: Business Wire)
Why: Early data are showing that the two-dose COVID-19 vaccine regimen for immunocompromised patients may not be enough to in some immunocompromised individuals help their immune system fight off the COVID-19 virus. The CDC recommended the third shot to help those whose immune systems may not have responded.
Who: Kristen Nichols, PharmD, BCPS, BCPPS, BCIDP, Senior Content Management Consultant, Pediatric Infectious Diseases, Wolters Kluwer, is a pharmacist who has been on the front lines of administering COVID-19 vaccines and is also an adjunct professor at Butler University. One detail she believes is missing from the conversation around the CDC and White House recommendations is the difference between a booster and a vaccine.
“The Advisory Committee on Immunization Practices (ACIP) has been particular about the terminology. What was authorized for immunocompromised patients is an additional dose, not a booster. An additional dose is for people who may not have responded adequately to the initial two-dose regimen, specifically those who are moderate to severely immunocompromised. A third dose doesn’t necessarily guarantee that they’ll respond, but several patients who received a solid organ transplant and didn’t respond to the initial 2 doses did respond to a third.”
“Boosters are doses that are given to people who likely had an adequate initial response but whose immunity may have waned over time. This would be your typical healthy person who got vaccinated originally but now needs to ‘re-invigorate’ that protection.”
How: Contact Ashley Beine at ashley.beine@wolterskluwer.com to schedule an interview with Kristen Nichols. Journalists may also publish the quote above with proper attribution.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
Media
Ashley Beine Sr. Public Relations and Public Affairs Specialist
Wolters Kluwer Health +1 (262) 685-8721
ashley.beine@wolterskluwer.com
Source: Wolters Kluwer Health
FAQ
What did the CDC recommend regarding COVID-19 vaccinations for immunocompromised patients and WTKWY?
The CDC recommends that immunocompromised patients receive an additional dose of COVID-19 mRNA vaccines made by Moderna and Pfizer.
What is the difference between a booster shot and an additional dose according to Wolters Kluwer and WTKWY?
A booster shot is for those with a healthy immune response whose protection may have waned, while an additional dose is for immunocompromised individuals who may not have responded adequately to the initial doses.
When should individuals receive their booster shot for COVID-19 according to the White House and WTKWY?
The White House suggests that individuals should start receiving a booster shot eight months after their second dose of the COVID-19 vaccine.
